Log In
Print
BCIQ
Print
Print this Print this
 

Oncophage, vitespen (Prophage) (formerly HSPPC-96)

  Manage Alerts
Collapse Summary General Information
Company Agenus Inc.
DescriptionVaccine containing the gp96 heat shock protein and associated peptides that are purified from autologous tumor cells
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today